Does ROSUVASTATIN Cause Intentional product use issue? 282 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 282 reports of Intentional product use issue have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.8% of all adverse event reports for ROSUVASTATIN.
282
Reports of Intentional product use issue with ROSUVASTATIN
0.8%
of all ROSUVASTATIN reports
4
Deaths
61
Hospitalizations
How Dangerous Is Intentional product use issue From ROSUVASTATIN?
Of the 282 reports, 4 (1.4%) resulted in death, 61 (21.6%) required hospitalization, and 12 (4.3%) were considered life-threatening.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 282 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which ROSUVASTATIN Alternatives Have Lower Intentional product use issue Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN